dobesilic acid Report issue

Small molecule Experimental
ChEMBL PubChem

Active Ingredient History

NOW
  • Now
Calcium dobesilate is a vasoprotective. It is the calcium salt of dobesilic acid. It is a synthetic molecule with the ability to reduce capillary permeability in the body. In Switzerland the drug is sold by the pharmaceutical company OM Pharma under the trade name of Doxium in capsules containing 500 mg of active ingredient.   Wikipedia

Chemistry

  • SMILES: O=S(=O)(O)c1cc(O)ccc1O
  • InChIKey: IKQCSJBQLWJEPU-UHFFFAOYSA-N
  • Mol. Mass: 190.18
  • ALogP: 0.34
  • ChEMBL Molecule:
    dobesilic acid  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Alternative names

dobesilic acid

Organizations (8)

Research & Development (8)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (4)

Approved Indications (1)


 

Hemorrhoids

Experimental Indications - Clinical Trial Phases 1-4 (4)


 

COVID-19 (Phase 2)

Diabetic Retinopathy (Phase 4)

Hemorrhoids ()

Kidney Failure, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial Organizations: 8

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue